Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

The association between perceived discrimination in midlife and peripheral neuropathy in a population-based cohort of women: the Study of Women's Health Across the Nation.

Dusendang JR, Reeves AN, Karvonen-Gutierrez CA, Herman WH, Ylitalo KR, Harlow SD.

Ann Epidemiol. 2019 Sep;37:10-16. doi: 10.1016/j.annepidem.2019.07.012. Epub 2019 Jul 27.

PMID:
31447292
2.

Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring.

Larkin ME, Nathan DM, Bebu I, Krause-Steinrauf H, Herman WH, Higgins JM, Tiktin M, Cohen RM, Lund C, Bergenstal RM, Johnson ML, Arends V; GRADE Research Group.

Diabetes Technol Ther. 2019 Sep 4. doi: 10.1089/dia.2019.0202. [Epub ahead of print]

PMID:
31393176
3.

Response to Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing. Diabetes Care 2019;42:576-584.

Evron JM, Herman WH, McEwen LN.

Diabetes Care. 2019 Jun;42(6):e103. doi: 10.2337/dci19-0016. No abstract available.

PMID:
31110127
4.

Evidence supports prediabetes treatment.

Neumiller JJ, Kalyani RR, Herman WH, Grant RW, Wysham CH, Inzucchi SE, Hirsch IB, Fonseca VA, Buse JB, Barrett EJ.

Science. 2019 Apr 26;364(6438):341-342. doi: 10.1126/science.aax3548. No abstract available.

PMID:
31023917
5.

Erratum. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017;40:1668-1677.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Apr;42(4):701. doi: 10.2337/dc19-er04. No abstract available.

6.

Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type I diabetes.

Sarma AV, Hotaling JM, de Boer IH, Dunn RL, Oerline MK, Singh K, Goldberg J, Jacobson A, Braffett B, Herman WH, Pop-Busui R, Wessells H; DCCT/EDIC Research Group.

J Hypertens. 2019 May;37(5):1070-1076. doi: 10.1097/HJH.0000000000001988.

PMID:
30882596
7.

Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing.

Evron JM, Herman WH, McEwen LN.

Diabetes Care. 2019 Apr;42(4):576-584. doi: 10.2337/dc17-1726. Epub 2019 Feb 6.

PMID:
30728220
8.

A new model for diabetes-focused capacity building - lessons from Sri Lanka.

Saha AK, Gunaratnam N, Patil R, Choo M, Bagchi DP, Jhaveri E, Wyckoff J, Bahu G, Balis U, Clyde P, Herman WH.

Clin Diabetes Endocrinol. 2018 Dec 12;4:22. doi: 10.1186/s40842-018-0074-3. eCollection 2018.

9.

Projecting ESRD Incidence and Prevalence in the United States through 2030.

McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM.

J Am Soc Nephrol. 2019 Jan;30(1):127-135. doi: 10.1681/ASN.2018050531. Epub 2018 Dec 17.

PMID:
30559143
10.

Genetic Ancestry Markers and Difference in A1c Between African American and White in the Diabetes Prevention Program.

Hivert MF, Christophi CA, Jablonski KA, Edelstein SL, Kahn SE, Golden SH, Dagogo-Jack S, Mather KJ, Luchsinger JA, Caballero AE, Barrett-Connor E, Knowler WC, Florez JC, Herman WH.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):328-336. doi: 10.1210/jc.2018-01416.

PMID:
30358859
11.

Recording of Diabetes on Death Certificates of Decedents With Type 1 Diabetes in DCCT/EDIC.

McEwen LN, Lee PG, Backlund JC, Martin CL, Herman WH.

Diabetes Care. 2018 Dec;41(12):e158-e160. doi: 10.2337/dc18-1704. Epub 2018 Oct 16. No abstract available.

PMID:
30327355
12.

Review of Metformin Use for Type 2 Diabetes Prevention.

Moin T, Schmittdiel JA, Flory JH, Yeh J, Karter AJ, Kruge LE, Schillinger D, Mangione CM, Herman WH, Walker EA.

Am J Prev Med. 2018 Oct;55(4):565-574. doi: 10.1016/j.amepre.2018.04.038. Epub 2018 Aug 17. Review.

13.

What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?

Herman WH, Braffett BH, Kuo S, Lee JM, Brandle M, Jacobson AM, Prosser LA, Lachin JM.

J Diabetes Complications. 2018 Oct;32(10):911-915. doi: 10.1016/j.jdiacomp.2018.05.007. Epub 2018 Jun 12.

14.
15.

Perceived stress across the midlife: longitudinal changes among a diverse sample of women, the Study of Women's health Across the Nation (SWAN).

Hedgeman E, Hasson RE, Karvonen-Gutierrez CA, Herman WH, Harlow SD.

Womens Midlife Health. 2018;4. pii: 2. doi: 10.1186/s40695-018-0032-3. Epub 2018 Mar 16.

16.

Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311.

Cefalu WT, Dawes DE, Gavlak G, Goldman D, Herman WH, Van Nuys K, Powers AC, Taylor SI, Yatvin AL; Insulin Access and Affordability Working Group.

Diabetes Care. 2018 Aug;41(8):1831. doi: 10.2337/dc18-er08. Epub 2018 Jun 28. No abstract available.

17.

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.

Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O'Connor PJ, Brandle M, Smolen HJ, Gahn JC, Valentine WJ, Pollock RF, Breeze P, Brennan A, Pollard D, Ye W, Herman WH, Isaman DJ, Kuo S, Laiteerapong N, Tran-Duy A, Clarke PM.

Value Health. 2018 Jun;21(6):724-731. doi: 10.1016/j.jval.2018.02.002. Epub 2018 Apr 9.

18.

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE.

Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18.

PMID:
29784612
19.

Diabetes and ischaemic stroke outcome.

MacDougal EL, Herman WH, Wing JJ, Morgenstern LB, Lisabeth LD.

Diabet Med. 2018 May 9. doi: 10.1111/dme.13665. [Epub ahead of print]

PMID:
29744920
20.

Insulin Access and Affordability Working Group: Conclusions and Recommendations.

Cefalu WT, Dawes DE, Gavlak G, Goldman D, Herman WH, Van Nuys K, Powers AC, Taylor SI, Yatvin AL; Insulin Access and Affordability Working Group.

Diabetes Care. 2018 Jun;41(6):1299-1311. doi: 10.2337/dci18-0019. Epub 2018 May 8. Review. No abstract available. Erratum in: Diabetes Care. 2018 Aug;41(8):1831.

PMID:
29739814
21.

Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial.

Kuo S, Ye W, Duong J, Herman WH.

Diabetes Res Clin Pract. 2018 Jul;141:181-189. doi: 10.1016/j.diabres.2018.04.040. Epub 2018 May 4.

PMID:
29730388
22.

The Cost of Diabetes Care-An Elephant in the Room.

Riddle MC, Herman WH.

Diabetes Care. 2018 May;41(5):929-932. doi: 10.2337/dci18-0012. No abstract available.

PMID:
29678864
23.

Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study.

Calles-Escandón J, Koch KL, Hasler WL, Van Natta ML, Pasricha PJ, Tonascia J, Parkman HP, Hamilton F, Herman WH, Basina M, Buckingham B, Earle K, Kirkeby K, Hairston K, Bright T, Rothberg AE, Kraftson AT, Siraj ES, Subauste A, Lee LA, Abell TL, McCallum RW, Sarosiek I, Nguyen L, Fass R, Snape WJ, Vaughn IA, Miriel LA, Farrugia G; NIDDK Gastroparesis Clinical Research Consortium (GpCRC).

PLoS One. 2018 Apr 13;13(4):e0194759. doi: 10.1371/journal.pone.0194759. eCollection 2018.

24.

Erratum. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation. Diabetes Care 2017;40:1668-1677.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2018 Apr;41(4):913. doi: 10.2337/dc18-er04. Epub 2018 Feb 23. No abstract available.

25.

Changes in Health Insurance Coverage Under the Affordable Care Act: A National Sample of U.S. Adults With Diabetes, 2009 and 2016.

Casagrande SS, McEwen LN, Herman WH.

Diabetes Care. 2018 May;41(5):956-962. doi: 10.2337/dc17-2524. Epub 2018 Feb 23.

PMID:
29475841
26.

The Effect of Attrition on Reported Diabetes Remission Rates Following Roux-en-Y Gastric Bypass: a Sensitivity Analysis.

Isaman DJM, Rothberg AE, Herman WH.

Obes Surg. 2018 May;28(5):1308-1312. doi: 10.1007/s11695-017-2995-9.

27.

Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2017 Dec;40(12):1668-1677. doi: 10.2337/dc17-1116. Epub 2017 Oct 11. Erratum in: Diabetes Care. 2018 Feb 23;:. Diabetes Care. 2019 Apr;42(4):701.

28.

Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.

Chamberlain JJ, Kalyani RR, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Herman WH.

Ann Intern Med. 2017 Oct 3;167(7):493-498. doi: 10.7326/M17-1259. Epub 2017 Sep 12.

PMID:
28892816
29.

Longitudinal Patterns of Occurrence and Remission of Erectile Dysfunction in Men With Type 1 Diabetes.

Palmer MR, Holt SK, Sarma AV, Dunn RL, Hotaling JM, Cleary PA, Braffett BH, Martin C, Herman WH, Jacobson AM, Wessells H; Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Research Group.

J Sex Med. 2017 Oct;14(10):1187-1194. doi: 10.1016/j.jsxm.2017.07.012. Epub 2017 Aug 26.

30.

Reply.

Stein JD, Wang SY, Herman WH, Andrews C, Gardner TW.

Ophthalmology. 2017 Sep;124(9):e69-e70. doi: 10.1016/j.ophtha.2017.03.067. No abstract available.

PMID:
28823356
31.

Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?

McEwen LN, Casagrande SS, Kuo S, Herman WH.

Curr Diab Rep. 2017 Sep;17(9):71. doi: 10.1007/s11892-017-0893-0. Review.

PMID:
28741264
32.

Response to Comment on American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S135.

Herman WH, Petersen M, Kalyani RR.

Diabetes Care. 2017 Jul;40(7):e94-e95. doi: 10.2337/dci17-0007. No abstract available.

PMID:
28637893
33.

Impact of weight loss on waist circumference and the components of the metabolic syndrome.

Rothberg AE, McEwen LN, Kraftson AT, Ajluni N, Fowler CE, Nay CK, Miller NM, Burant CF, Herman WH.

BMJ Open Diabetes Res Care. 2017 Feb 20;5(1):e000341. doi: 10.1136/bmjdrc-2016-000341. eCollection 2017.

34.

Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.

Chamberlain JJ, Herman WH, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Kalyani RR.

Ann Intern Med. 2017 Apr 18;166(8):572-578. doi: 10.7326/M16-2937. Epub 2017 Mar 14.

PMID:
28288484
35.

Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177-e178.

Balkau B, Soulimane S, Simon D, Herman WH.

Diabetes Care. 2017 Mar;40(3):e36. doi: 10.2337/dc16-2000. No abstract available.

PMID:
28223448
36.

The global agenda for the prevention of type 2 diabetes.

Herman WH.

Nutr Rev. 2017 Jan;75(suppl 1):13-18. doi: 10.1093/nutrit/nuw034. Review.

37.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Obes Surg. 2017 Jan;27(1):2-21. doi: 10.1007/s11695-016-2457-9.

PMID:
27957699
38.

Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.

Wang SY, Andrews CA, Herman WH, Gardner TW, Stein JD.

Ophthalmology. 2017 Apr;124(4):424-430. doi: 10.1016/j.ophtha.2016.10.031. Epub 2016 Nov 30.

39.

How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review.

Hua X, Lung TW, Palmer A, Si L, Herman WH, Clarke P.

Pharmacoeconomics. 2017 Mar;35(3):319-329. doi: 10.1007/s40273-016-0466-0. Review.

40.

Sweet taste preferences before and after an intensive medical weight loss intervention.

Asao K, Rothberg AE, Arcori L, Kaur M, Fowler CE, Herman WH.

Obes Sci Pract. 2016 Jun;2(2):189-195. Epub 2016 Mar 18.

41.

Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Pop-Busui R, Braffett BH, Zinman B, Martin C, White NH, Herman WH, Genuth S, Gubitosi-Klug R; DCCT/EDIC Research Group.

Diabetes Care. 2017 Jan;40(1):94-100. doi: 10.2337/dc16-1397. Epub 2016 Nov 1.

42.

Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.

Lenherr SM, Clemens JQ, Braffett BH, Dunn RL, Cleary PA, Kim C, Herman WH, Hotaling JM, Jacobson AM, Brown JS, Wessells H, Sarma AV; DCCT/EDIC Research Group.

Diabet Med. 2016 Nov;33(11):1528-1535. doi: 10.1111/dme.13126. Epub 2016 Apr 24.

43.

Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass.

Isaman DJ, Rothberg AE, Herman WH.

Diabetes Care. 2016 Dec;39(12):2247-2253. Epub 2016 Oct 13.

44.

Operationalizing and Examining Family Planning Vigilance in Adult Women With Type 1 Diabetes.

Sereika SM, Becker D, Schmitt P, Powell AB 3rd, Diaz AM, Fischl AF, Thurheimer-Cacciotti J, Herman WH, Charron-Prochownik D.

Diabetes Care. 2016 Dec;39(12):2197-2203. Epub 2016 Oct 11.

45.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Surg Obes Relat Dis. 2016 Jul;12(6):1144-62. doi: 10.1016/j.soard.2016.05.018.

PMID:
27568469
46.

Cost of Antihyperglycemic Medications in the United States--Reply.

Hua X, Herman WH, Clarke P.

JAMA. 2016 Aug 9;316(6):665-6. doi: 10.1001/jama.2016.8596. No abstract available.

PMID:
27532928
47.

The Clinical and Public Health Challenges of Diabetes Prevention: A Search for Sustainable Solutions.

Wareham NJ, Herman WH.

PLoS Med. 2016 Jul 26;13(7):e1002097. doi: 10.1371/journal.pmed.1002097. eCollection 2016 Jul.

48.
49.

Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes.

Hotaling JM, Sarma AV, Patel DP, Braffett BH, Cleary PA, Feldman E, Herman WH, Martin CL, Jacobson AM, Wessells H, Pop-Busui R; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

Diabetes Care. 2016 Sep;39(9):1587-93. doi: 10.2337/dc16-0059. Epub 2016 Jun 28.

50.

Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S52-S59.

Herman WH, Kalyani RR, Wexler DJ, Matthews DR, Inzucchi SE.

Diabetes Care. 2016 Jun;39(6):e88-9. doi: 10.2337/dci16-0003. No abstract available.

Supplemental Content

Loading ...
Support Center